Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Improve symptoms of dry eye disease by careful selection of appropriate topical treatments

    • 35 Accesses

    This is a preview of subscription content, log in to check access.

    Table I

    References

    1. 1.

      Foulks GN. Pharmacological management of dry eye in the elderly patient. Drugs Aging 2008; 26(2): 105–18

    2. 2.

      Dry Eye Workshop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007 Apr; 5(2): 75–92

    3. 3.

      Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: 25 year review. Cornea 2000 Sep; 19(5): 644–9

    4. 4.

      Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004 Nov; 23(8): 762–70

    5. 5.

      Burstein NL. The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc U K 1985; 104 (Pt 4): 402–9

    6. 6.

      Holly FJ, Lamberts DW. Effect of nonisotonic solutions on tear film osmolality. Invest Ophthalmol Vis Sci 1981 Feb; 20(2): 236–45

    7. 7.

      Yancey PH. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J Exp Biol 2005 Aug; 208 (Pt 15): 2819–30

    8. 8.

      Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res 2004 Jan; 28(1): 55–62

    9. 9.

      Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease: CsA Phase 3 Study Group. Ophthalmology 2000 Apr; 107(4): 631–9

    10. 10.

      Di Pascuale MA, Goto E. Tseng SC. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients. Ophthalmology 2004 Apr; 111(4): 783–91

    11. 11.

      Korb DR, Scaffidi RC, Greiner JV, et al. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci 2005; 82(7): 594–601

    12. 12.

      Sall KN, Cohen SM, Christensen MT, et al. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens 2006 Jan; 32(1): 21–6

    13. 13.

      Tang-Liu DD-S, Acheampong A. Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. Clin Pharmacokinet 2005; 44(3): 247–61

    14. 14.

      Horrobin DF. Essential fatty acid and prostaglandin metabolism in Sjögren’s syndrome, systemic sclerosis, and rheumatoid arthritis. Scand J Rheumatol Suppl 1986; 61: 242–5

    15. 15.

      Miljanovic B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005 Oct; 82(4): 887–93

    16. 16.

      Barabino S. Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an in-flammatory component. Cornea 2003 Mar; 22(2): 97–101

    17. 17.

      Pflugfelder SC. Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol 2006 Aug; 142(2): 316–7

    18. 18.

      Weber J, Keating GM. Cevimeline. Drugs 2008; 68(12): 1691–8

    19. 19.

      Sullivan DA, Wickham LA, Rocha EM, et al. Androgens and dry eye in Sjögren’s syndrome. Ann N Y Acad Sci 1999 Jun; 876: 312–24

    20. 20.

      Sullivan DA. Sex and sex steroid influences on dry eye syndrome. In: Pflugfelder SC, Beuerman RW, Stern ME, editors. Dry eye and ocular surface disease. New York: Marcel Dekker, Inc., 2004: 165–90

    21. 21.

      Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and dry eye syndrome. JAMA 2001; 286(17): 2114–9

    22. 22.

      Kramer P, Lubkin V, Potter W, et al. Cyclic changes in conjunctival smears from menstruating females. Ophthalmology 1990 Jan; 97(1): 303–7

    23. 23.

      Scott G, Yiu SC, Wasilewski D, et al. Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women. Am J Ophthalmol 2005; 139(6): 1109–10

    24. 24.

      Connor CG. Symptomatic relief of dry eye assessed with the OSDI in patients using 5% testosterone cream. Invest Ophthalmol Vis Sci 2005; 46: E-abstract 2032

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Improve symptoms of dry eye disease by careful selection of appropriate topical treatments. Drugs Ther. Perspect 24, 12–14 (2008). https://doi.org/10.2165/0042310-200824120-00004

    Download citation